Finland· FI-REL-REL59532

octaplasLG

A blood substitutes and plasma protein fractions product containing human plasma protein, registered in Finland by Octapharma AB. The same ATC class is registered in 7 of our 19 countries.

ATC B05AA

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedoctaplasLGATCB05AAREGISTER NO.FI-REL-REL59532PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Human plasma protein is registered in 7 of 19 countries.

Countries holding a registration under ATC B05AA (blood substitutes and plasma protein fractions), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Human plasma protein · ATC B05AA

7 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Human plasma protein
Manufacturer
Octapharma AB
Country
Finland (FI)
ATC code
B05AA
ATC class
Blood substitutes and plasma protein fractions
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Human plasma protein in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human plasma protein products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Albunorm, Alburex
  • Belgium · Alburex, Human Albumin Csl Behring
  • Bulgaria · Албурекс, Октапласlg
  • Cyprus · Albumeon, Alburex
  • Czechia · Alburex, Human Albumin Csl Behring
  • Germany · Albumeon, Albunorm
  • Denmark · Albumin Behring, Albunorm
  • Estonia · Human Albumin Csl Behring, Octaplaslg
  • Spain · Albúmina Humana Csl Behring, Albunorm
  • France · Albumine Humaine Csl Behring, Albunorm
  • United Kingdom (Northern Ireland) · Albumeon, Alburex
  • Greece · Albumeon, Alburex
  • Croatia · Albumeon, Albunorm
  • Hungary · Alburex, Human Albumin Csl Behring
  • Ireland · Alburex, Human Albumin Csl Behring
  • Iceland · Albumin Behring, Albunorm
  • Italy · Albumeon, Albunorm
  • Lithuania · Human Albumin Csl Behring, Octaplasma
  • Luxembourg · Alburex, Human Albumin Csl Behring
  • Latvia · Human Albumin Csl Behring, Octaplasma
  • Malta · Albumeon, Alburex
  • Netherlands · Albunorm, Alburex
  • Norway · Albumin Behring, Albunorm
  • Poland · Alburex, Human Albumin Csl Behring
  • Portugal · Albumina Humana Csl Behring, Alburex
  • Romania · Albumeon, Alburex
  • Sweden · Albumin Behring, Albunorm
  • Slovenia · Alburex, Humani Albumin Csl Behring
  • Slovakia · Alburex, Human Albumin Csl Behring

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/47d0a3bc-fafa-4c35-8b76-4cf780ae1834
GET /v1/drugs/47d0a3bc-fafa-4c35-8b76-4cf780ae1834?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "infuusiokuiva-aine ja liuotin, liuosta varten",
  "route": "Laskimoon",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Veren korvikkeet ja plasman proteiinifraktiot",
  "ma_number": "40471",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL59532",
  "authorised_at": "2023-03-24"
}

See everything about human plasma protein.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.